Please provide your email address to receive an email when new articles are posted on . A 54-year-old man was referred in late 2014 for a consultation for corneal transplant surgery in the left eye.
Please provide your email address to receive an email when new articles are posted on . Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and ...
On Monday, Glaukos Corporation (NYSE:GKOS) received the “Day 74” notification from the U.S. Food and Drug Administration (FDA) acknowledging the previously submitted New Drug Application (NDA) for ...
SHERBORN, Mass.--(BUSINESS WIRE)--CXL Ophthalmics, Inc., a clinical-stage company developing a minimally-invasive treatment for keratoconus, today published results of the EpiSmart cross-linking Phase ...
Keratoconus is a progressive eye disorder characterized by thinning and bulging of the cornea, leading to visual distortion.
Credit: Glaukos. Epioxa does not require the removal of the corneal epithelium, a step usually required by traditional corneal cross-linking procedures, thereby minimizing pain and recovery time.
A Clarenville man is asking the province to pay for surgery to keep him from losing his vision to a rare eye disease. Wyatt Ellis says he needs cornea cross-linking surgery but Newfoundland and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results